Mirae Asset Capital Life Science Inception I, LP Submits SEC Filing
Mirae Asset Capital Life Science Inception I, LP filed a document with the SEC on May 11, 2026, under Item 3C of the Investment Company Act, specifically referencing Section 3(c)(1), according to SEC EDGAR.
Details of the Filing
The filing, with accession number 0002131585-26-000001, is for Mirae Asset Capital Life Science Inception I, LP and has a size of 8 KB. It explicitly mentions Item 3C.1 as Section 3(c)(1), as recorded in the SEC EDGAR system.
Background on the Filer
Mirae Asset Capital Life Science Inception I, LP is the entity associated with CIK number 0002131585, which submitted this filing. As is widely known, such filings often relate to exemptions under the Investment Company Act.
Regulatory Aspects
The document pertains to the Investment Company Act Section 3(c), with a focus on Section 3(c)(1), according to SEC EDGAR.
